Theragnostex, the newest company to join the University City Science Center’s Port business incubator, has developed a method that can both diagnose cancer and monitor patient responses to therapy via a simple blood test. Medical professionals are always looking to ...
Read More »Exosome assay developer Theragnostex working on partnership with CliniCan Health Research
Theragnostex is in discussion with CliniCan Health Research on possible partnerships and strategies to acquire Series A funding. CliniCanHealth Research provides specialized services to Pharmaceutical and Biotech companies for their therapeutic development. We use intelligent scientific methodologies, involving current Research & ...
Read More »